Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose Optimisation With Angiotensin II Antagonist Losartan in Patients With Hypertension and Other Risk Factors for Metabolic Syndrome (GOAAL)

NCT00237588 is registered in ClinicalTrials.gov with Ullevaal University Hospital as lead sponsor.

NCT NCT00237588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose Optimisation With Angiotensin II Antagonist Losartan in Patients With Hypertension and Other Risk Factors for Metabolic Syndrome (GOAAL)
Lead sponsor
Ullevaal University Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
July 31, 2005
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension